MeiraGTx Enters Material Agreement, Takes on New Financial Obligation
Ticker: MGTX · Form: 8-K · Filed: Mar 26, 2026 · CIK: 0001735438
Complexity: simple
Sentiment: mixed
Topics: material-agreement, debt, financial-obligation
TL;DR
**MeiraGTx just signed a big deal or took on new debt, watch for details.**
AI Summary
MeiraGTx Holdings plc filed an 8-K on March 26, 2026, detailing an "Entry into a Material Definitive Agreement" and "Creation of a Direct Financial Obligation." This indicates the company has entered into a significant new contract or taken on new debt. For investors, this matters because such agreements can significantly impact the company's financial health, future revenue streams, or debt burden, potentially affecting stock valuation.
Why It Matters
This filing signals a potentially significant change in MeiraGTx's financial structure or operational strategy, which could impact its future profitability and risk profile.
Risk Assessment
Risk Level: medium — The filing indicates new financial obligations or agreements without specific details, creating uncertainty about their positive or negative impact.
Analyst Insight
A smart investor would seek out the full text of the EX-99.1 exhibit mentioned in the filing to understand the specifics of the 'Material Definitive Agreement' and 'Direct Financial Obligation' to assess their impact on MeiraGTx's future.
Key Players & Entities
- MeiraGTx Holdings plc (company) — the filer of the 8-K
- 0001735438 (company) — CIK of MeiraGTx Holdings plc
- 2026-03-26 (date) — filing date of the 8-K
- 2026-03-25 (date) — period of report for the 8-K
FAQ
What specific items were reported in this 8-K filing by MeiraGTx Holdings plc?
MeiraGTx Holdings plc reported under Item 1.01: Entry into a Material Definitive Agreement, Item 2.02: Results of Operations and Financial Condition, Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, and Item 9.01: Financial Statements and Exhibits.
When was this 8-K filing accepted by the SEC?
This 8-K filing was accepted by the SEC on 2026-03-26 at 08:25:09.
What is the CIK number for MeiraGTx Holdings plc?
The CIK number for MeiraGTx Holdings plc is 0001735438.
What is the business address listed for MeiraGTx Holdings plc in this filing?
The business address listed for MeiraGTx Holdings plc is 655 THIRD AVENUE SUITE 1115 NEW YORK NY 10017.
What is the SIC code for MeiraGTx Holdings plc and what does it represent?
The SIC code for MeiraGTx Holdings plc is 2836, which represents Biological Products, (No Diagnostic Substances).
Filing Stats: 923 words · 4 min read · ~3 pages · Grade level 11.1 · Accepted 2026-03-26 08:25:09
Key Financial Figures
- $0.00003881 — on which registered Ordinary Shares, $0.00003881 par value per share MGTX The Nasda
- $15.00 — of the Company at an exercise price of $15.00 per share and (ii) 300,000 ordinary sha
- $20.00 — of the Company at an exercise price of $20.00 per share, which Warrants were granted
- $25,000,000 — the Notes Purchase Agreement) equal to $25,000,000 on or before June 30, 2026. The Warrant
- $8.00 — amended to change the exercise price to $8.00 per Warrant Share (as defined under the
Filing Documents
- mgtx-20260325x8k.htm (8-K) — 40KB
- mgtx-20260325xex99d1.htm (EX-99.1) — 174KB
- mgtx-20260325xex99d1001.jpg (GRAPHIC) — 3KB
- 0001104659-26-034904.txt ( ) — 347KB
- mgtx-20260325.xsd (EX-101.SCH) — 3KB
- mgtx-20260325_lab.xml (EX-101.LAB) — 16KB
- mgtx-20260325_pre.xml (EX-101.PRE) — 10KB
- mgtx-20260325x8k_htm.xml (XML) — 5KB
01. Entry Into a Material Definitive Agreement
Item 1.01. Entry Into a Material Definitive Agreement. On March 25, 2026, MeiraGTx Holdings plc (the "Company"), as issuer, and its wholly-owned subsidiaries MeiraGTx UK II Limited, a company incorporated in England and Wales ("MeiraGTx UK II"), and MeiraGTx Ireland DAC, a designated activity company limited by shares incorporated in Ireland ("MeiraGTx Ireland," and together with MeiraGTx UK II, the "Subsidiary Guarantors"), the noteholders and other parties from time to time party to the Notes Purchase Agreement (as defined below), and Perceptive Credit Holdings III, LP, as administrative agent and noteholder under the Notes Purchase Agreement ("Perceptive"), entered into Amendment No. 4 to Amended and Restated Notes Purchase Agreement and Amendment No. 1 to Warrant Certificates (the "Amendments"). The Amendments amend (A) the Amended and Restated Notes Purchase Agreement and Guaranty, dated December 19, 2022, between the Company, the Subsidiary Guarantors, the noteholders and other parties from time to time party thereto, and Perceptive (the "Notes Purchase Agreement"), and (B) the warrants (the "Warrants") granted to Perceptive to purchase up to (i) 400,000 ordinary shares of the Company at an exercise price of $15.00 per share and (ii) 300,000 ordinary shares of the Company at an exercise price of $20.00 per share, which Warrants were granted in August 2022 at the time the Company entered into the initial financing with Perceptive. Under the Amendments, the Maturity Date (as defined under the Notes Purchase Agreement) has been extended from August 2, 2026 to May 2, 2027 and the Company has agreed to redeem a portion of the outstanding principal amount of the Notes (as defined under the Notes Purchase Agreement) equal to $25,000,000 on or before June 30, 2026. The Warrants were amended to change the exercise price to $8.00 per Warrant Share (as defined under the Warrants). Ellen Hukkelhoven, Ph.D., a member of the Company's Board of Directors, is Head of Biot
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On March 26, 2026, the Company issued a press release announcing its financial results for the year ended December 31, 2025. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Item 2.02 (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as expressly set forth by specific reference in such filing. Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information described in Item 1.01 regarding the financial obligations under the Amendments and the Notes Purchase Agreement is incorporated by reference into this Item 2.03.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release of MeiraGTx Holdings plc, dated March 26, 2026. 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded in the Inline XBRL document). -2- SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: March 26, 2026 MEIRAGTX HOLDINGS PLC By: /s/ Richard Giroux Name: Richard Giroux Title: Chief Financial Officer and Chief Operating Officers -3-